Contents
Download PDF
pdf Download XML
427 Views
134 Downloads
Share this article
Research Article | Volume 13 Issue:3 (, 2023) | Pages 1373 - 1378
A Study of Procalcitonin as an Early Predictor of Severity in Acute Pancreatitis
Under a Creative Commons license
Open Access
Received
July 4, 2023
Revised
July 18, 2023
Accepted
Aug. 1, 2023
Published
Aug. 26, 2023
Abstract

Introduction: Acute pancreatitis is an acute inflammatory process ranging clinically from mild discomfort with localized inflammation to severe disease involving remote organ systems. Aim: Study of procalcitonin as an early predictor of severity in acute pancreatitis. Methods: This study was a Hospital based observational study conducted on 56 cases aged between 18 to 80 years at acute pancreatitis patients presenting in OPD and IPD of medicine and gastroenterology department at SMS Medical College and Hospital, Jaipur, Rajasthan, India. Data collection was started after approval from institutional research review board. Results: majority 46.4% patients were of 20-40 years age group, mean age was 43.69 years, 71.4% patients were male, 44.6% patients were alcoholic. Majority 37.5% patients were of Ranson score 2, as per Atlanta criteria, 66.07% patients were of mild acute pancreatitis, 10.7% patients died. Conclusion: We have observed that Procalcitonin has shown promising results as an early marker of development of complications.

Keywords
Recommended Articles
Research Article
Assessing the Relationship Between Thiazide Use and Syncope Or Fall in Hypertensive Indian Subjects Admitted to the Tertiary Care Hospital
...
Published: 24/05/2025
Download PDF
Research Article
Evaluation of Matrix Metalloproteinases-3 As A Possible Biomarker For Oral Sub Mucous Fibrosis
Published: 24/11/2025
Download PDF
Research Article
Correlation Between Electrographic Changes and Troponin I Levels in Patients Presenting with Chest Pain in Emergency Medicine Department of Tertiary Care Centre
...
Published: 16/11/2025
Download PDF
Short Commentary Article
Commentary: Crystalline Precision: The Clinical Impact of Co-Crystal Formulation Differences in Sacubitril/Valsartan for HFrEF
Published: 22/11/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.